FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
mskcc.org
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug, trastuzumab deruxtecan (T-DXd), was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist ...
Aug 5, 2022
Trastuzumab Side Effects
Herceptin (Trastuzumab) Side Effects and Screening
9:24
Herceptin (Trastuzumab) Side Effects and Screening
YouTubeVincent Stevenson
7.4K viewsApr 14, 2018
Trastuzumab || What Are The Side Effects?? || Avoid With Easy 7 Steps || Dr. Bharat Patodiya
6:02
Trastuzumab || What Are The Side Effects?? || Avoid With Easy 7 Steps || Dr. Bharat Patodiya
YouTubePi Cancer Care
21.5K viewsMar 22, 2022
Trastuzumab Deruxtecan's Impressive CR Rates & Managing Side Effects
1:10
Trastuzumab Deruxtecan's Impressive CR Rates & Managing Side Effects
YouTubeThe Oncology Brief
30 views5 months ago
Top videos
Dr. Pegram on the Development of Trastuzumab Biosimilars | OncLive
Dr. Pegram on the Development of Trastuzumab Biosimilars | OncLive
onclive.com
Apr 29, 2019
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars | OncLive
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars | OncLive
onclive.com
Oct 27, 2018
Dr. Rugo Discusses the Equivalency of Trastuzumab Biosimilars | OncLive
Dr. Rugo Discusses the Equivalency of Trastuzumab Biosimilars | OncLive
onclive.com
Nov 3, 2018
Trastuzumab Mechanism of Action
Trastuzumab Mechanism of Action in HER2 Positive Breast Cancer | Olakunle Odutola posted on the topic | LinkedIn
Trastuzumab Mechanism of Action in HER2 Positive Breast Cancer | Olakunle Odutola posted on the topic | LinkedIn
linkedin.com
1 week ago
Mechanism of Action: Herceptin (Trastuzumab) | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Mechanism of Action: Herceptin (Trastuzumab) | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
targetedonc.com
Jun 29, 2013
Mechanism of Action | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
5:07
Mechanism of Action | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
enhertuhcp.com
May 26, 2020
Dr. Pegram on the Development of Trastuzumab Biosimilars | OncLive
Dr. Pegram on the Development of Trastuzumab Biosimilars | OncLive
Apr 29, 2019
onclive.com
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars | OncLive
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilar…
Oct 27, 2018
onclive.com
Dr. Rugo Discusses the Equivalency of Trastuzumab Biosimilars | OncLive
Dr. Rugo Discusses the Equivalency of Trastuzumab Biosimilars | Onc…
Nov 3, 2018
onclive.com
Biosimilars
Biosimilars
Apr 2, 2022
gastro.org
LBA1 - Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with high-risk human epidermal growth factor receptor 2–positive (HER2 ) primary breast cancer (BC) with residual invasive disease after neoadjuvant therapy (tx): Interim analysis of DESTINY-Breast05 | OncLive
LBA1 - Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (…
6 months ago
onclive.com
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
5:05
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
166.4K viewsApr 30, 2013
YouTubeHMP Education
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer
3:50
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer
45.2K viewsOct 21, 2015
YouTubeOncology Associates
22:53
Trastuzumab deruxtecan (T-DXd) + Pertuzumab FDA Approval in Adv …
4.2K views3 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discus…
FDA Officially Accepts the BLA Resubmission by Sandoz Ag for T…
Jul 15, 2024
marketscreener.com
1:50
Findings of a Biosimilar Trastuzumab Study in Patients Wit…
169 viewsSep 21, 2016
YouTubeTargeted Oncology
1:47
The use of trastuzumab and biosimilars in the treatment of bre…
350 viewsAug 17, 2017
YouTubeVJHemOnc – Video Journal of Hematology & H…
Sandoz AG Re-Submits the Biosimilar Drug EG12014 (Trastuz…
Jun 13, 2024
marketscreener.com
3:45
Trastuzumab-Deruxtecan: A Game-Changer in HER2-Positive Cancer…
3.9K viewsAug 5, 2024
YouTubePharmacology Insights
3:15
What Is Trastuzumab (Herceptin) Used For In HER2-positive Breast …
17 views6 months ago
YouTubeBreast Cancer Support Channel
2:19
Trastuzumab grafted PAMAM dendrimers for the selective delive…
6.1K viewsJun 22, 2017
YouTubeScientific Reports
3:32
ENHERTU: Breakthrough Hope for HER2 Positive Cancers
50.2K viewsSep 2, 2023
YouTubePharma News & Analysis
5:46
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HE…
3.2K viewsJan 7, 2020
YouTubeecancer
3:04
Trastuzumab Deruxtecan for HER2+ Breast Cancer
8.4K viewsMar 27, 2018
YouTubeOncLive
8:42
Trastuzumab Deruxtecan in HER2+ Breast Cancer
509 viewsJul 7, 2020
YouTubeTargeted Oncology
2:47
Biosimilars: Approval Process
12.4K viewsDec 17, 2021
YouTubeU.S. Food and Drug Administration
0:34
Herceptin: Mechanism of action
52.7K viewsAug 2, 2007
YouTubeCancerQuest-CJ
5:59
What is Trastuzumab Derukstekan (Enhertu)? What Should Patients …
775 views7 months ago
YouTubeProf. Dr. Mustafa Özdoğan
35:22
Is T-DXd + Pertuzumab the New FirstLine Standard? - Drs. Neil Iye…
5.4K views4 months ago
YouTubeCommunity Health Media
7:44
Treatment Options for HER2+ Breast Cancer: A Comprehensive Guide …
16.4K viewsAug 16, 2024
YouTubeYerbba – Breast Cancer
1:52
HER2 Expression: Beyond the Binary
13.7K views10 months ago
YouTubeCommunity Health Media
3:43
Evolving Role of Trastuzumab Deruxtecan in HER2+/HER2-Low …
3.7K viewsJan 30, 2020
YouTubeOncLive
0:39
Journey Through Trastuzumab Treatment: Cycle 14 of 18
2.2K views2 months ago
TikTokcheskapulia
1:01
Dr. Brufsky on Trastuzumab Biosimilars in Breast Cancer
134 viewsDec 18, 2019
YouTubeOncLive
1:16
Dr. Mitri Discusses the Promise of Trastuzumab Biosimilars
47 viewsJun 12, 2018
YouTubeOncLive
See more videos
Static thumbnail place holder